论文期刊

取消

高级检索

检索历史清除

首页> The journal of vascular access> Different risk factors are associated with vascular access patency after construction and percutaneous transluminal angioplasty in patients starting hemodialysis.

Different risk factors are associated with vascular access patency after construction and percutaneous transluminal angioplasty in patients starting hemodialysis.

导出 LinkOut

翻译打印收藏纠错

作者： Mahoko,Yoshida ^[1] ; Shigehiro,Doi ^[1] ; Ayumu,Nakashima ^[1] ; Yasufumi,Kyuden ^[2] ; Toru,Kawai ^[3] ; Koichiro,Kawaoka ^[4] ; Shunsuke,Takahashi ^[5] ; Toshinori,Ueno ^[6] ; Yoshiko,Nishizawa ^[7] ; Takao,Masaki ^[8]

作者单位： Department of Nephrology, Hiroshima University Hospital, Hiroshima, Japan. ^[1] Department of Stem Cell Biology and Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan. ^[2] Jinyukai Onomichi Clinic, Onomichi, Japan. ^[3] Chuou Naika Clinic, Kure, Japan. ^[4] Department of Nephrology, Kure Kyosai Hospital, Kure, Japan. ^[5] Department of Nephrology, National Hospital Organization Kure Medical Center, Kure, Japan. ^[6] Department of Nephrology, Hiroshima Prefectural Hospital, Hiroshima, Japan. ^[7] Department of Nephrology, Ichiyokai Harada Hospital, Hiroshima, Japan. ^[8]

关键词 Hemodialysis patency rate percutaneous transluminal angioplasty vascular access

主题词血管成形术(Angioplasty);血管成形术, 气囊(Angioplasty, Balloon);动静脉转流术, 外科(Arteriovenous Shunt, Surgical);女(雌)性(Female);移植物闭塞, 血管(Graft Occlusion, Vascular);人类(Humans);肾透析(Renal Dialysis);回顾性研究(Retrospective Studies);危险因素(Risk Factors);血管未闭(Vascular Patency)

DOI 10.1177/1129729820959934

PMID 32985321

发布时间 2022-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览8

The journal of vascular access

The journal of vascular access

2021年22卷5期

707-715页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷